CNXC Concentrix Corporation

NASDAQ
$24.91

Concentrix Beats on Profit and Cash, but a Second Revenue Cut and a Q4 Decline Guide Push the Growth Story Toward 2028

Concentrix (CNXC) delivered another profit beat in its fiscal third quarter, but the top line kept deteriorating and management cut the revenue outlook again. Non-GAAP EPS of $2.92 topped the $2.71 consensus by 9.4% and cleared the $2.67 Earnings Whisper number. Earnings Whispers' normalized figures show 18.7% year-over-year earnings growth. The company's own reconciliation measures the gain against a $2.78 prior-year figure, a more modest $0.14 improvement. Revenue of $2.454 billion fell 1.2% from a year ago and missed consensus by 1.1%. On a constant-currency basis, revenue slipped 0.5%, below the low end of the company's own $2.465-$2.490 billion guide. That is the central tension. Concentrix is squeezing more profit and cash out of a shrinking revenue base while betting that its AI-era business can outgrow the erosion of its legacy book.

The quality of the beat deserves scrutiny, though it is not hollow. Non-GAAP operating income of $309.0 million exceeded the high end of guidance, and the non-GAAP operating margin widened 30 basis points to 12.6%. Adjusted free cash flow of $218 million was a third-quarter record, up from $179 million a year earlier. Debt fell by $211 million, including repayment of $200 million of August notes. Restructuring and integration charges, which are excluded from the adjusted numbers, more than doubled to $42.5 million from $18.6 million. That shows the cost-cutting behind the margin gains is not free. On a GAAP basis, the quarter was a $16.24 per-share loss driven by a $1.05 billion non-cash goodwill impairment, which the company tied to its stock price and market capitalization. That follows a $1.52 billion write-down in the fourth quarter of fiscal 2025. Two impairments in three quarters are a blunt acknowledgment that the market has repriced the legacy franchise.

The industry mix shows where the pressure sits. Technology and consumer electronics revenue fell 10%, communications and media fell 7%, and healthcare dropped 17%. Banking, financial services and insurance grew 12%, and retail, travel and e-commerce rose 6%. On the call, the constant-currency trajectory told the story plainly:

- Q4 FY25: +3.1%

- Q1: +1.9%

- Q2: +0.6%

- Q3: -0.5%

- Q4 guide: -3% to -5%

Full-year revenue guidance now calls for a 0.3% to 0.8% constant-currency decline. That compares with growth of 1.5% to 3% at the start of the year and 0.25% to 1.25% after the second quarter. Management attributed the fourth-quarter step-down largely to two hyperscaler clients that pulled forward the end of support for certain customer sets into Q4. Those exits had previously been spread through the second quarter of fiscal 2027. Faster AI automation deployments are also compressing traditional revenue, and the offshore/nearshore shift in delivery mix is now a roughly 3-point revenue headwind, up from the 2 points assumed at the start of the year.

The call did preserve a credible transformation narrative. New business now exceeds 50% of revenue about a quarter and a half ahead of schedule. Management defines this bucket as AI-influenced or transformed work, IX Suite-driven revenue and new high-value services. It is growing roughly 30% this year with markedly higher retention, and management expects it to top $6 billion in 2027. Other supporting data points:

- AI-related new-logo sales rose 63% sequentially.

- IX Suite is tracking toward roughly $120 million in exit ARR, up from $60 million exiting fiscal 2025.

- The Castle Hill acquisition adds risk and compliance capabilities.

- The dividend was raised to $0.37.

The forward framing, however, has softened. Management's early 2027 view calls for higher free cash flow, stable-to-improved margins and new-business growth offsetting "much if not all" automation, but growth will be back-half weighted. A return to mid-single-digit growth is now positioned as a 2028 event, whereas the fourth-quarter fiscal 2025 call described the company as on the path to that level. The year-end leverage target also shifted from "below 2.6x" to "approximately 2.6x."

The market setup is more complicated than the surprise implies. Shares closed at $25.45 ahead of the report, up 27.1% from the $20.02 open after the June release. They are nonetheless 24.8% below the $33.84 inter-earnings high set on September 1, meaning much of the rally had already faded. The stock remains 15.5% below its 200-day moving average, and the quarter's low of $19.12 on June 30 was also a 52-week low. Investor sentiment stayed negative and weakened modestly, from -0.36 to -0.41. The Earnings Whispers trend signals lean negative, with AVWAP negative and price and momentum only neutral.

The bottom line is that Concentrix executed well on the levers it controls: margins, cash conversion and debt reduction, with the full-year EPS midpoint nudged slightly higher to $10.97-$11.09. The revenue line is moving the wrong way faster than planned, and the timetable for a return to real growth slipped again. Bulls can point to a new-business engine that is growing about 30% and now represents most of the company. Bears have legitimate ammunition in a second straight revenue cut, a Q4 decline guide, repeated impairments and a growth recovery now framed around 2028. Until the new business visibly outruns the legacy runoff, profit beats alone are unlikely to settle that debate.

← Back to CNXC news